Proactive Investors - Run By Investors For Investors

Live Company to kick off Great Brick Safari tour of USA and Europe later this month

The tour will begin at Twycross Zoo near Birmingham, before heading to eight other zoos across
lego zebra
The shows will feature 70 life-size LEGO animals

Live Company Group Plc’s (LON:LVCG) latest acquisition, Bright Bricks, is to take its life-size LEGO animals on a tour of zoos in Europe and the USA later this month.

The Great Brick Safari, which will feature 70 LEGO animals, including an African elephant and a Bengal tiger, will be at Twycross Zoo near Birmingham until the start of January.

READ: Live Company acquires Bright Bricks

Bright Bricks, the world’s largest independent LEGO brick building company, has contracted with eight additional zoos and parks, including a major zoo in Europe and the USA.

The plan is to form more partnerships with other venues around the world, while Live said it was in talks to take a new show back to Marwell Zoo, where it all began last year.

The Bright Bricks shows will be incorporated into the group’s BRICKLIVE TOURING division. That arm of the company also includes the BRICKLIVE Animal Paradise shows, which recently kicked off a three-year tour of China.

“We are pleased to be confirming the launch of our touring concept in zoos and parks in the US and Europe, which was one of our strategies for the recent acquisition of Bright Bricks,” said executive chairman David Ciclitira.

“Combining the Great Brick Safari package with the success of BRICKLIVE ANIMAL PARADISE enables BRICKLIVE TOURING to strengthen and in turn ensure the capacity for an additional range of concepts, strengthening the group as a global children's entertainment and education brand.”

View full LVCG profile View Profile

Live Company Group Plc Timeline

Related Articles

Mobile users holding phones up
September 05 2018
The mobile advertiser is placing itself at the forefront of the digital revolution as companies and brands increasingly look to the web as the next forefront of advertising
December 19 2018
Interim profits showed a modest recovery with the number of contracts signed rising to 77 from 74 a year earlier
September 19 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use